Member Info for Riesgo

Another milestone perhaps?

See Poster, posted by Poirot. Text above Table 2.

Back in the noughties the SP was over £10. Maybe this is ramping, but I’m enjoying it, so I don’t care.

Showing on ADVFN. 510,000.
Looking good for FOMO Friday.

In the January Antibody RNS AS said; 'We believe COVID-19 testing remains a long-term commercial opportunity. We will therefore use the robustness of the Affimer® platform, and what we have learned about the SARS-CoV-2 virus, to generate the next generation antigen test that will be as resilient as possible to any future mutations'.
That was over 2 months ago. Could 'long-term' be a bit longer than 'shortly'?

I agree Skel except I think it takes a little time to affect the SP. When it’s clear the shorters are moving out then the SP should start to increase. A fall first thing tomorrow to clear away the stop loss orders and then the rise will begin if we see the short has reduced. I’m thinking it will be a good time to pile in again. End of year results due at the end of this month / early April.

Let’s hope they’ve stopped wasting time & money on it. It might have the potential to be the best, but the first attempt was so far away from the target, it would make more sense to offer Affimers to someone who has proven they can make and sell LFTs.

If the initial trials have been successful, then I hope Avacta is trying to get into the arms of patients asap. Agree it’s important to establish the dangerous toxic load. But is there any reason to delay getting the successful safe dose into patients arms? I know I would want it. Sorry if some find this annoying.

I always believed AffiDX was at least going to be a good advertisement for Affimers.

Mr A post reported for being abusive without reason.
Will also be filtered shortly.

Instead, we get to draw our own conclusions without the withheld information.
Maybe it’s the same reason why information saliva test and antibody tests was withheld, for example.

Now you are being silly PL75.
If any have survived that would be good to hear and not just from a drug success perspective. The completed Chemo sessions would also be good to know. None of this information would affect the patients or their bereaved loved ones. AS knows, so why can’t we know too?
I will be filtering you shortly because it seems you are too sensitive to handle an adult discussion.

It would be good to know;
How many of the 4 are still alive.
How many completed all doses. If all doses were completed that would be major detail to know. (My wife was forced to miss two Chemo sessions because her body couldn’t cope).
Why isn’t AS giving this detail? Is it like the information on Saliva tests and Antibody tests?

Thanks for explaining that apple tree, but I was expecting 18 times more Dox delivered to its target, even with a slightly lower than normal dose. Surely producing a very noticeable effect. So why no information about this? And why 50%? Why not 10% or 200%. There must be reasons know to AS.

Thanks for that MCB55. I must have missed that about 4 patients. I figured it must be safe so far. I guess my feeling of being duped with Affimers/Antibodies is affecting me. I’m also kicking myself because I purchased a box of AffiDX last September and my immediate impression on opening the box and using one was that they look crap when compared to others. I kept that to myself with hope they were so good and could be quickly adapted for the next variant that looks didn’t really matter.

Why isn’t AS telling us more details about the trials? Why, for example, doesn’t he use plain English and say how many patients? Have they fared better than expected or as expected (18 times better)? It would improve my confidence if he was not so tight with information he has.

Watching2 filtered. Anymore sensitive souls out there, just let me know.

My comment is not about how the test is manufactured. AS led us to believe our LFT could be quickly adapted for variants because of Affimers are being used in place of antibodies. Then he drops a bombshell saying he is pulling our LFT because there’s a problem with the Antibodies it uses. Like everyone else I was sold a pup.
Eventually we will find out what AS knows about the initial results. If good then I’ll be in again, but too risky for me to trust anything coming out of AS right now. So be it if the price is much higher when I do.

‘No fault of Avacta’ you must be joking. AS is the big cheese and he told us Affimer in place of Antibodies ensures rapid adjustment of our LFT to deal with variants. Did he not?
It’s also what he doesn’t say that is important. Why boost the dose by 50% if precision gives a 18 fold boost? AS knows why but isn’t saying. Is it because they could not spot any difference except to confirm no significant damage is caused and they need to whack up the dose to spot any difference?
I’d love to believe again but staying out until I do.

Did you ever get yourself an LFT from BioServ? I did and it needs a lot more tweaking than its ANTIBODIES.
Think I’ll put some on EBay soon so you can see for yourself.
In case you are wondering I am fully sold with a big loss, but looking to return eventually.